Bibliographic Details
| Title: |
The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial |
| Authors: |
van Tilborg Theodora C, Eijkemans Marinus JC, Laven Joop SE, Koks Carolien AM, de Bruin Jan, Scheffer Gabrielle J, van Golde Ron JT, Fleischer Kathrin, Hoek Annemieke, Nap Annemiek W, Kuchenbecker Walter KH, Manger Petra A, Brinkhuis Egbert A, van Heusden Arne M, Sluijmer Alexander V, Verhoeff Arie, van Hooff Marcel HA, Friederich Jaap, Smeenk Jesper MJ, Kwee Janet, Verhoeve Harold R, Lambalk Cornelis B, Helmerhorst Frans M, van der Veen Fulco, Mol Ben Willem J, Torrance Helen L, Broekmans Frank JM |
| Source: |
BMC Women's Health, Vol 12, Iss 1, p 29 (2012) |
| Publisher Information: |
BMC, 2012. |
| Publication Year: |
2012 |
| Collection: |
LCC:Gynecology and obstetrics
LCC:Public aspects of medicine |
| Subject Terms: |
Ovarian reserve, Antral follicle count, IVF, Individualised FSH stimulation dosages, Live birth rate, Gynecology and obstetrics, RG1-991, Public aspects of medicine, RA1-1270 |
| More Details: |
Abstract Background Costs of in vitro fertilisation (IVF) are high, which is partly due to the use of follicle stimulating hormone (FSH). FSH is usually administered in a standard dose. However, due to differences in ovarian reserve between women, ovarian response also differs with potential negative consequences on pregnancy rates. A Markov decision-analytic model showed that FSH dose individualisation according to ovarian reserve is likely to be cost-effective in women who are eligible for IVF. However, this has never been confirmed in a large randomised controlled trial (RCT). The aim of the present study is to assess whether an individualised FSH dose regime based on an ovarian reserve test (ORT) is more cost-effective than a standard dose regime. Methods/Design Multicentre RCT in subfertile women indicated for a first IVF or intracytoplasmic sperm injection cycle, who are aged Discussion The results of this study will be integrated into a decision model that compares cost-effectiveness of the three dose-adjustment strategies to a standard dose strategy. The study outcomes will provide scientific foundation for national and international guidelines. Trial registration NTR2657 |
| Document Type: |
article |
| File Description: |
electronic resource |
| Language: |
English |
| ISSN: |
1472-6874 |
| Relation: |
http://www.biomedcentral.com/1472-6874/12/29; https://doaj.org/toc/1472-6874 |
| DOI: |
10.1186/1472-6874-12-29 |
| Access URL: |
https://doaj.org/article/d2ee761780044a36abf3e5f4d1cdd670 |
| Accession Number: |
edsdoj.2ee761780044a36abf3e5f4d1cdd670 |
| Database: |
Directory of Open Access Journals |
